Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) EV to CFO (2021 - 2025)

Invivyd's (IVVD) quarterly EV to CFO came in at 12.86 in Q4 2025, down 3008.78% on a YoY basis from 0.44 in Q4 2024, and down 3.75% quarter-over-quarter from 12.39 in Q3 2025.

Analysis

Invivyd (IVVD) EV to CFO (2021 - 2025) Analysis & Trends

Invivyd (IVVD) has reported EV to CFO for 5 consecutive years, with 12.86 the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, EV to CFO fell 3008.78% year-over-year to 12.86; the trailing twelve-month figure through Dec 2025 stood at 3.42 (down 3605.42% YoY), and the FY2025 full-year result was 3.42, down 3605.42% from the prior year.
  • EV to CFO fell to 12.86 in Q4 2025 per IVVD's latest filing, from 12.39 in the prior quarter.
  • Across five years, EV to CFO topped out at 3.18 in Q4 2021 and bottomed at 38.94 in Q3 2021.
  • Historically, EV to CFO has averaged 4.24 across 5 years, with a median of 0.74 in 2022.
  • The widest YoY moves for EV to CFO: up 114.92% in 2024, down 5823.75% in 2024.
  • Over 5 years, EV to CFO stood at 3.18 in 2021, then slumped by 147.43% to 1.51 in 2022, then slumped by 161.24% to 3.94 in 2023, then soared by 111.22% to 0.44 in 2024, then tumbled by 3008.78% to 12.86 in 2025.
  • According to Business Quant data, EV to CFO over the past three periods registered 12.86, 12.39, and 3.79 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -12.86
Sep 30, 2025 -12.39
Jun 30, 2025 -3.79
Mar 31, 2025 -1.19
Dec 31, 2024 0.44
Sep 30, 2024 -0.37
Jun 30, 2024 0.40
Mar 31, 2024 -6.77
Dec 31, 2023 -3.94
Sep 30, 2023 -0.14
Jun 30, 2023 0.18
Mar 31, 2023 -0.11
Dec 31, 2022 -1.51
Sep 30, 2022 -1.12
Jun 30, 2022 2.06
Mar 31, 2022 0.54
Dec 31, 2021 3.18
Sep 30, 2021 -38.94